Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04739722 · ClinicalTrials.gov registry record · NA
Colorectal Cancer and Pre-Cancerous Adenoma Non-Invasive Detection Test Study
A NA study, sponsored by Geneoscopy.
- Completed
- Registry status
- NA
- Development phase
- 14,263
- Enrollment target
NCT04739722 is a NA study that has completed, run by Geneoscopy. The registered enrollment target is 14,263 participants.
The verdict
NCT04739722, a NA study, has completed, sponsored by Geneoscopy.
- COMPLETED
- Registry status
- NA
- Development phase
- 14,263 participants
- Enrollment target
Study Summary
This study was a prospective analysis conducted by Geneoscopy Inc. to evaluate the ColoSense test, which is a multi-target stool RNA test for colorectal cancer screening.
Interventions
- DIAGNOSTIC_TEST ColoSense
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14,263 participants |
| Start Date | 2021-04-12 |
| Est. Completion | 2024-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04739722
The ClinicalTrials.gov registry entry for NCT04739722 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14,263 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Geneoscopy, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ColoSense is the first listed.
NCT04739722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04739722 about?
NCT04739722 is a clinical study titled "Colorectal Cancer and Pre-Cancerous Adenoma Non-Invasive Detection Test Study". This study was a prospective analysis conducted by Geneoscopy Inc. to evaluate the ColoSense test, which is a multi-target stool RNA test for colorectal cancer screening.
What is the current status of trial NCT04739722?
This trial is currently completed. It is a NA study. The enrollment target is 14,263 participants. The study started on 2021-04-12. Estimated completion is 2024-01-31.
What interventions are being tested in trial NCT04739722?
The interventions under investigation include: ColoSense (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04739722?
This trial is sponsored by Geneoscopy, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.